started · updated
Amdocs shares plunge following T-Mobile legal dispute
Amdocs shares fell over 40% in premarket trading after the company revealed a legal dispute with T-Mobile. The conflict could lead to a projected 7% to 11% decline in annual revenue by 2027, alongside significant drops in earnings per share.
T-Mobile has been a long-standing client of Amdocs for approximately two decades. In the 2025 fiscal year, T-Mobile accounted for 19.9% of Amdocs’ total revenue, contributing roughly $900 million. Despite a recent multi-year agreement to integrate GenAI technologies, the relationship has shifted following strategic changes at T-Mobile.
The dispute has resulted in nearly $3 billion being removed from Amdocs’ market capitalization, bringing its value to approximately $3.6 billion.